Tag: GlobeNewswire

Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics’ Syracuse facility in New York

Strategic long-term partnership to increase Alvotech’s global manufacturing capacity and support growth in demand

REYKJAVIK, Iceland, and SEOUL, South Korea (October 6, 2026) – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and LOTTE Biologics, a contract development and manufacturing (CDMO) organization, today announced a long-term strategic manufacturing partnership.

Under the agreement, LOTTE Biologics will manufacture drug substance for multiple antibody biosimilar products at its Syracuse facility in New York for global supply, with the potential to further expand the collaboration over time. The Syracuse facility has 40,000 liters of bioreactor capacity for biologics manufacturing, supported by on-site process development and quality control capabilities. The site has an established track record in commercial biologics manufacturing and recently completed an unannounced FDA inspection with zero observations, further demonstrating its strong quality and regulatory capabilities.

The agreement expands Alvotech’s US-based manufacturing footprint while strengthening its global supply network. The additional capacity complements Alvotech’s existing manufacturing partnerships and its in-house development and manufacturing capabilities, supporting its expanding portfolio and providing greater flexibility to meet demand across international markets.

“Alvotech has one of the most comprehensive, internally developed product portfolios in the industry,” said Lisa Graver, CEO of Alvotech. “With the expansion of our global manufacturing network, we will have sufficient capacity to meet demand for our pipeline for the next ten years. Our collaboration with LOTTE Biologics will bring additional manufacturing capacity in New York to support patients worldwide, complementing our existing capabilities as we scale our portfolio and prepare for future launches.”

“Alvotech’s expertise in biosimilar development, combined with LOTTE Biologics’ manufacturing capabilities, creates a strong foundation for this collaboration,” said James Park, CEO of LOTTE Biologics. “We look forward to strategically supporting Alvotech’s growing portfolio and the reliable supply of high-quality, more affordable biologic medicines to patients worldwide. With our Syracuse operations and the completion of our Songdo Bio Campus, we are committed to providing flexible, dual-site manufacturing support as the partnership grows.”

Commercial supply will be subject to successful technology transfer, manufacturing qualification and applicable regulatory approvals.

For further information, contact:

Media
Benedikt Stefansson
Sarah MacLeod
alvotech.media@alvotech.com

Investors
Dr. Balaji V Prasad
Benedikt Stefansson
Mikaela Vilchez
alvotech.ir@alvotech.com

About Alvotech

Alvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high-quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Five biosimilars are already approved and marketed in multiple global markets, including biosimilars to Humira® (adalimumab), Stelara® (ustekinumab), Simponi® (golimumab), Eylea® (aflibercept) and Prolia®/Xgeva® (denosumab). The current development pipeline includes disclosed biosimilar candidates aimed at treating autoimmune disorders, eye disorders, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. For more information, please visit https://www.alvotech.com. None of the information on the Alvotech website shall be deemed part of this press release.

For more information, please visit our  website or follow us on social media on LinkedIn, Facebook, Instagram, and YouTube.

About LOTTE Biologics

LOTTE Biologics is a global contract development and manufacturing organization (CDMO) providing an integrated biologics solutions to pharmaceutical and biotechnology companies worldwide. With its established commercial manufacturing operations in Syracuse, New York, and the newly completed Songdo Bio Campus in South Korea, LOTTE Biologics is building a flexible, dual-site manufacturing network to support customers from development through commercial supply.

For more information, please visit our website or Linkedin.

Forward Looking Statements

Certain statements in this communication may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include, for example, Alvotech’s expectations regarding competitive advantages, business prospects and opportunities including pipeline product development, future plans and intentions, regulatory submissions, review and interactions, the potential approval and commercial launch of its product candidates, the timing of regulatory approval, market launches and financial projections. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Alvotech and its management, are inherently uncertain and are inherently subject to risks, variability, and contingencies, many of which are beyond Alvotech’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in documents that Alvotech may from time-to-time file or furnish with the SEC. There may be additional risks that Alvotech does not presently know or that Alvotech currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, assurance, prediction or definitive statement of a fact or probability. Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred to in this communication. Alvotech disclaims any and all liability for any loss or damage (whether foreseeable or not) suffered or incurred by any person or entity as a result of anything contained or omitted from this communication and such liability is expressly disclaimed.

WINTER PARK, Fla., Oct. 06, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, today announced that Christine Plummer, Chief Financial Officer, will present and host in-person one-on-one meetings with investors at the ThinkEquity Conference, taking place on October 15, 2026 at the Mandarin Oriental Hotel in New York City.

Presentation Details

The live presentation will begin at 4:00 p.m. ET on Thursday, October 15, 2026 at the Mandarin Oriental Hotel, 80 Columbus Circle, New York, NY. A live webcast of the presentation will be available on the Events page of the Streamex investor relations website at https://ir.streamex.com/news-events/events. A replay of the webcast will be available for 90 days following the presentation. Streamex will also host in-person one-on-one meetings with investors on Thursday, October 15, 2026. To register for the presentation or to request a one-on-one meeting, please contact ThinkEquity at conference@think-equity.com.

About ThinkEquity

ThinkEquity is a boutique investment bank that provides a suite of capital markets and advisory services to growth companies, including initial public offerings (IPOs), secondary offerings, confidentially marketed public offerings (CMPOs), registered direct offerings, at-the-market offerings (ATMs), debt placement and acquisition financing. The ThinkEquity Conference brings together U.S. and international public and private companies, industry executives, and institutional and accredited investors for company presentations and one-on-one meetings. For more information, visit www.think-equity.com.

About Streamex Corp.

Streamex Corp. (NASDAQ: STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.

For more information, visit www.streamex.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex’s business strategy, product development, and participation in the ThinkEquity Conference. These statements are based on current expectations and assumptions subject to risks and uncertainties beyond Streamex’s control, and actual results may differ materially, including as a result of market conditions, regulatory developments, and macroeconomic factors affecting digital asset markets. A discussion of these and other factors is set forth in Streamex’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Streamex undertakes no obligation to update any forward-looking statements except as required by law.

Contacts

Laura Kiernan	Christine Plummer
Head of Investor Relations, Streamex Corp.	Chief Financial Officer, Streamex Corp.
IR@streamex.com | 1-914-598-7733	www.streamex.com | X.com/streamex

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) —

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
09/30/2026	100,732,781	105,563,044

For further information on Cellectis, please contact:         

Media contacts:              
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com  
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93      
    
Investor Relations contact:           
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com   

Attachment

• Voting_Rights_PR_Sept_2026_EN

MIAMI, Oct. 06, 2026 (GLOBE NEWSWIRE) — USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for the quarter ended September 30, 2026, after the market closes on Thursday, October 22, 2026.

A conference call to discuss quarterly results will also be held with Chairman, President, and CEO, Luis de la Aguilera, Chief Financial Officer, Robert Anderson, and Chief Credit Officer, Sergio Garrido, details which are provided below.

Live Conference Call and Audio Webcast

Date: Friday, October 23, 2026
Time: 11:00am Eastern Time
Dial-in: (833) 816-1416 (toll free in the U.S.)
Passcode: USCB Financial Holdings Call

A live audio webcast of the call will be available with the press release and slides on the investor relations page of the Company’s website at https://investors.uscenturybank.com/. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the internet broadcast.

A replay of the webcast will be archived on the investor relations page shortly after the conference call has ended.

About USCB Financial Holdings, Inc.

USCB Financial Holdings, Inc. is the bank holding company for U.S. Century Bank. Established in 2002, U.S. Century Bank is one of the largest community banks headquartered in Miami, and one of the largest community banks in the state of Florida. U.S. Century Bank is rated 5-Stars by BauerFinancial, the nation’s leading independent bank rating firm. U.S. Century Bank offers customers a wide range of financial products and services and supports numerous community organizations, including the Greater Miami Chamber of Commerce, the South Florida Hispanic Chamber of Commerce, and ChamberSouth. For more information or to find a U.S. Century Bank banking center near you, please call (305) 715-5200 or visit www.uscentury.com.

Contacts:

Investor Relations
InvestorRelations@uscentury.com 

Media Relations
Martha Guerra-Kattou
MGuerra@uscentury.com

MINEOLA, N.Y., Oct. 06, 2026 (GLOBE NEWSWIRE) — Hanover Bancorp, Inc. (Nasdaq: HNVR) (the “Company”), parent company of Hanover Community Bank (the “Bank”), today announced the opening of its newest full-service branch at 205 Osborn Avenue, Riverhead, New York. This location is Hanover Bank’s eleventh branch. It reflects Hanover’s disciplined growth strategy of expanding into communities with strong economic momentum and further expands its presence on Long Island, particularly in Suffolk County. Together with its Hauppauge Business Center and Port Jefferson branch, the Riverhead branch strengthens the Bank’s ability to serve this region with local decision-making, personalized service, and comprehensive financial solutions.

“Riverhead is a natural fit for Hanover’s continued growth across Long Island,” said Michael P. Puorro, Chairman and Chief Executive Officer of Hanover Community Bank. “The community is experiencing a remarkable transformation, and we see tremendous opportunity to partner with local businesses, families, community organizations, and public-sector leaders. As we evaluated where to grow next, Riverhead stood out as a market where our relationship-focused approach and professional expertise can make a meaningful difference. We look forward to building lasting relationships and supporting the community’s continued success.”

The Riverhead branch also serves as a business banking center offering a full range of personal, business, and municipal banking services. This location is staffed with dedicated business bankers who can provide local businesses with direct access to their years of banking expertise and support their growth.

“Our strategy has never been simply to open branches; it is to become part of the communities we serve, “Mr. Puorro added.” That begins with hiring talented professionals who know the local market because they live and work there. Their insight allows us to make decisions close to our clients and deliver the tailored service that defines Hanover. That is what it means to move Forward Together.”

The Riverhead branch represents another milestone in Hanover Bank’s long-term expansion across Suffolk County and the greater New York metropolitan area. We look forward to meeting our new neighbors, committing to the growth of the community and assisting in any way we can to help our clients achieve their financial goals.

About Hanover Community Bank and Hanover Bancorp, Inc.

Hanover Bancorp, Inc. (NASDAQ: HNVR), is a bank holding company for Hanover Community Bank, a community commercial bank focusing on highly personalized and efficient services and products responsive to client needs. Management and the Board of Directors are comprised of a select group of successful local businessmen and women who are committed to the success of the Bank by knowing and understanding the metro-New York area’s financial needs and opportunities. Backed by state-of-the-art technology, Hanover offers a full range of financial services. Hanover employs a complete suite of consumer, commercial, and municipal banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit. Hanover also offers its customers access to 24-hour ATM service with no fees attached, free checking with interest, telephone banking, advanced technologies in mobile and internet banking for our consumer and business customers, safe deposit boxes and much more. The Company’s corporate administrative office is located in Mineola, New York where it also operates a full-service branch office along with additional branch locations in the Bowery, Forest Hills, Flushing, Garden City Park, Hauppauge, Port Jefferson, Sunset Park, Rockefeller Center, New York, and Freehold, New Jersey.

Hanover Community Bank is a member of the Federal Deposit Insurance Corporation and is an Equal Housing/Equal Opportunity Lender. For further information, call (516) 548-8500 or visit the Bank’s website at www.hanoverbank.com.

Investor and Press Contact:
Lance P. Burke
Senior Executive VP – Chief Financial Officer
(516) 548-8500

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHP) (“NHP”) announced today that it will release its financial results for the quarter ended September 30, 2026 after market close on Wednesday, November 4, 2026.

NHP’s executive leadership will also host a conference call and webcast on Thursday, November 5, 2026, beginning at 10:00 a.m. ET, to review the third quarter results.

The dial in numbers for the conference call are 1-833-461-5787 (U.S. & Canada) and +1-585-542-9983 (International) and the Meeting ID is 851 315 324. Alternatively, you can pre-register for the call here. Upon pre-registering for the call, a unique dial-in code will be emailed directly to your email, avoiding any wait times on hold.

Shortly after the conclusion of the conference call, a webcast replay will be available on NHP’s investor website or by clicking here.

About National Healthcare Properties, Inc.

National Healthcare Properties, Inc. (Nasdaq: NHP) is a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States. Additional information about the Company can be found on its website at nhpreit.com.

Contacts

Investors and Media:
Email: ir@nhpreit.com

SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling approximately 900 individuals. Merit employs approximately 7,500 people worldwide.

Contacts:
PR/Media Inquiries: Sarah Comstock Merit Medical	Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare
+1-801-432-2864	+1-443-213-0509
sarah.comstock@merit.com	mike.piccinino@icrhealthcare.com

SRX to dividend ETF holdings to shareholders 

Initial ETF to feature an actively managed digital asset hedging strategy powered by EMJX’s proprietary AI technology

NORTH PALM BEACH, Fla., Oct. 06, 2026 (GLOBE NEWSWIRE) — SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced a $1.5 million commitment to launch a new family of actively managed Exchange Traded Funds (ETFs) through its EMJX platform, marking the first step in bringing EMJX’s proprietary AI-driven investment intelligence to the broader investing public.

The ETF family will be actively managed by Eric Jackson, President, EMJX Platform and Head of Asset Management. Kupa AI, an AI fintech company co-founded by Andy Kim, will oversee the logistics of the launch.

Andy Kim is the Co-Founder of Kupa AI, which develops and operates a global suite of financial products across stocks, bonds, prediction markets, and copy trading under the Unlok brand. Prior to founding Kupa AI, Mr. Kim was Co-Founder, Chief Investment Officer, and Managing Member of Pinz Capital Management, a New York-based hedge fund focused on relative value, event-driven, special situations, and systematic market-neutral strategies across more than 40 countries. Earlier in his career, he was a hedge fund manager at leading global investment firms, including Millennium Management and Paloma Partners. Mr. Kim holds a degree in Economics and Statistics from the University of Chicago and a Master’s degree in Financial Engineering from the University of California, Berkeley.

EMJX expects its first ETF to be available to retail and institutional investors in the first quarter of 2027. The initial fund will execute a specialized hedging strategy for digital assets, powered by EMJX’s proprietary AI-driven regime model, which is designed to identify shifts in market conditions and adjust portfolio exposure across bullish, bearish, and mixed market environments.

The ETF launch represents a significant milestone in the commercialization of the EMJX platform. As previously discussed, the Company has received inbound interest from parties seeking access to the EMJX model, including ETF sponsors, digital asset treasuries, and other institutional investors. Unlike many actively managed strategies that are available only to accredited investors through private vehicles, an exchange-traded structure is expected to make EMJX’s approach accessible to any investor with a brokerage account.

“We are consistently looking for unique, technology-enabled opportunities that drive tangible value for our shareholders,” said Kent Cunningham, Chief Executive Officer of SRX Global Inc. “Bringing EMJX to market through an ETF puts our proprietary intelligence in front of a far broader universe of investors, while keeping SRX shareholders directly aligned with its success. Eric leads the investment strategy, and with Andy and the Kupa AI team overseeing launch logistics, we believe we have the right partners in place to execute. By providing the initial capital for this launch, we are backing a differentiated product built on our own technology and creating a direct link between its growth and value for our shareholders.”

In keeping with the Company’s ongoing commitment to returning value to its shareholders, SRX intends to dividend its holdings from this ETF launch directly to SRX shareholders. Additional details, including timing and record date, will be announced at a later date.

Eric Jackson, President, EMJX Platform and Head of Asset Management, added, “We are thrilled to bring this innovative family of ETFs to both retail and institutional investors. Strategies designed to actively manage digital asset volatility have largely been the domain of hedge funds and private vehicles. By leveraging EMJX’s proprietary technology, our first offering is designed to provide a disciplined hedging strategy for digital assets, addressing a critical need in today’s dynamic market. I look forward to working alongside Andy and the Kupa AI team to bring this strategy to market.”

About SRX Global Inc.
SRX Global is an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements, including statements regarding the Company’s investment strategy, capital allocation and portfolio positioning, the anticipated benefits and timing of the EMJX ETF launches, the receipt of required regulatory approvals, the performance of third parties, including Kupa AI, the form, timing, and tax treatment of any dividend of ETF holdings to shareholders, the ability to make dividend payments to shareholders, and the anticipated performance of the digital asset hedging strategy. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy shares of any ETF. Any offering of ETF shares will be made only by means of a prospectus filed with the Securities and Exchange Commission.

Company Contact
SRX Global Inc.
Kent Cunningham, Chief Executive Officer

Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
srx@kcsa.com

LOS ANGELES, Oct. 06, 2026 (GLOBE NEWSWIRE) — AXIL Brands, Inc. (“AXIL,” “we,” “us,” “our,” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, and marketing services for third-party brands today announced financial and operational results for the first fiscal quarter ended August 31, 2026.

First Quarter Financial Highlights (Period-ended August 31, 2026)

(All comparisons are to the three months ended August 31, 2025 unless otherwise stated)

• Net revenues were $6.1 million, compared with $6.9 million in the prior-year period, a decrease of 11.2%. The comparison reflects the planned transition from XCOR to XCOR II and a material prior-year big-box order that did not repeat in the quarter. Direct-to-consumer revenue in the hearing segment was down less than 1%
• Gross profit was $5.0 million, or 82.6% of sales, compared with $4.6 million, or 67.6% of sales. The current-quarter margin included a non-recurring $0.55 million benefit from IEEPA customs duty refunds recognized as a reduction of cost of revenues. Excluding that item, gross margin was approximately 73.6%
• Income from operations was $437,000, compared with $412,000 in the prior-year period
• Net income was $0.4 million, or $0.05 per diluted share, compared with $0.3 million, or $0.04 per diluted share
• Adjusted EBITDA was $0.8 million, compared with $0.7 million
• Net cash provided by operating activities was $3.8 million, compared with $739,000 used in the prior-year period
• Cash was $7.9 million as of August 31, 2026, compared with $4.5 million as of May 31, 2026, with no outstanding borrowings

First Quarter Operational Update

• On August 26, 2026, the Company announced XCOR II, the next-generation successor to its flagship AXIL wireless earbud line, with availability beginning September 15, 2026.
• Initial XCOR II orders exceeded $2.8 million as of August 26, 2026 and $3.6 million as of September 30, 2026. Shipments are underway in the second quarter of fiscal 2027.
• First-quarter results included advertising costs of approximately $360,000 and inventory staging related to XCOR II launch. That spend and those shipments did not benefit first-quarter revenue; the Company anticipates they will convert to revenue in the second quarter.
• The Company brought three strategic partners into Reviv3 ProCare Company (“Reviv3”) to lead the planned global relaunch of the Reviv3 hair and skin care brand. In exchange for services, the partners received an approximately 25% ownership interest in Reviv3 in the aggregate. AXIL retains approximately 75% of Reviv3’s ownership interest and continues to consolidate Reviv3 results. The shares were valued at $137,511, which was recorded as a non-cash expense in the first quarter of fiscal 2027.
• The Company received $0.9 million in IEEPA customs duty refunds, including interest, from U.S. Customs and Border Protection. Of this amount, $0.55 million related to duties on products already sold and was recognized as a reduction of cost of revenues, $0.32 million related to products still in inventory and was recorded as a reduction of inventory, and $0.04 million was interest included in other income. No IEEPA refund claims remain outstanding.

Management Commentary

“The principal development of the quarter was the launch of XCOR II,” said Jeff Toghraie, Chairman and Chief Executive Officer. “XCOR II was announced in August, became available on September 15, and generated orders exceeding $3.6 million through September 30 across retail, distribution, and direct-to-consumer, the strongest early demand we have seen for an AXIL product. First-quarter revenue does not yet reflect that launch. The quarter included the expected slowing of first generation XCOR, the advertising and inventory required to bring XCOR II to market, and a prior-year big-box order that did not repeat. Direct-to-consumer revenue in hearing enhancement and protection was down less than 1 percent. We expect that launch investment and those orders will be reflected in second quarter revenue and beyond.”

“Reported gross margin included a non-recurring customs duty refund. Underlying margin was 73.6 percent, in line with our history. Those refunds have been collected, and no claims remain outstanding. We ended the quarter with $7.9 million of cash and no debt, and by September 30, 2026, we had fulfilled the majority of the XCOR II order backlog. On Reviv3, we brought in experienced partners, retained control, and did so without deploying AXIL cash. We are optimistic about fiscal 2027 and focused on building long-term value for shareholders.”

Use of Non-GAAP Financial Measures

The Company calculates EBITDA by taking net income calculated in accordance with accounting principles generally accepted in the United States (“GAAP”), and adjusting for income taxes, interest income or expense, and depreciation and amortization. The Company calculates adjusted EBITDA as EBITDA, further adjusted for stock-based compensation. Adjusted EBITDA is also presented as a percentage of revenue, which is calculated by dividing the non-GAAP Adjusted EBITDA for a period by revenue for the same period. Other companies may calculate EBITDA and adjusted EBITDA differently, limiting the usefulness of these measures for comparative purposes. The Company believes that these non-GAAP measures of financial results provide useful information regarding certain financial and business trends relating to the Company’s financial condition and results of operations, and management considers EBITDA and adjusted EBITDA important indicators in evaluating the Company’s business on a consistent basis across various periods for trend analyses. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements and are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. Investors should not rely on any single financial measure to evaluate our business. A reconciliation of EBITDA and Adjusted EBITDA to the most comparable financial measure, net income, calculated in accordance with GAAP is included in a schedule to this press release.

AXIL BRANDS, INC. AND SUBSIDIARIES
CONSOLIDATED EBITDA and ADJUSTED EBITDA
FOR THE THREE MONTHS ENDED AUGUST 31, 2026 AND 2025

(UNAUDITED)

		For the Three Months Ended
		August 31, 2026				August 31, 2025
Net income (GAAP)		$	420,571			$	334,294
Provision for income taxes			99,590				115,058
Interest income, net			(81,251	)			(36,296	)
Depreciation and amortization			65,538				62,087
Total EBITDA (Non-GAAP)			504,448				475,143
Adjustments:
Stock-based compensation			322,393				199,212
Total adjusted EBITDA (Non-GAAP)		$	826,841			$	674,355
Revenues, net (GAAP)		$	6,090,383			$	6,856,218
Adjusted EBITDA as a percentage of Revenues, net (Non-GAAP)			13.6	%			9.8	%

AXIL BRANDS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

		August 31, 2026				May 31, 2026
		(Unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents		$	7,928,587			$	4,462,040
Accounts receivable, net			1,326,395				4,748,966
Inventory, net			4,438,940				4,419,628
Due from related party			78,822				—
Prepaid expenses and other current assets			956,930				712,214
Total Current Assets			14,729,674				14,342,848
OTHER ASSETS:
Property and equipment, net			418,684				389,733
Intangible assets, net			460,470				389,747
Right of use assets			310,828				360,512
Deferred tax asset			491,119				301,460
Other assets			20,720				20,720
Goodwill			2,152,215				2,152,215
Total Other Assets			3,854,036				3,614,387
TOTAL ASSETS		$	18,583,710			$	17,957,235
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Accounts payable		$	2,440,224			$	1,989,048
Contract liabilities, current			297,724				389,333
Due to related party			—				152,177
Lease liabilities, current			191,297				195,563
Income tax liability			958,744				688,150
Other current liabilities			566,284				1,088,262
Total Current Liabilities			4,454,273				4,502,533
LONG TERM LIABILITIES:
Lease liabilities			161,179				209,105
Contract liabilities			81,077				101,380
Total Long Term Liabilities			242,256				310,485
Total Liabilities			4,696,529				4,813,018
Commitments and contingencies
EQUITY:
Series A Preferred Stock, $0.0001 par value; 27,773,500 shares designated; 24,873,500 and 24,873,500 shares issued and outstanding as of August 31, 2026 and May 31, 2026, respectively			2,487				2,487
Common stock, $0.0001 par value: 15,000,000 shares authorized; 6,822,681 and 6,822,681 shares issued and outstanding as of August 31, 2026 and May 31, 2026, respectively			682				682
Additional paid-in capital			9,892,683				9,720,981
Retained Earnings			3,841,659				3,420,067
Total stockholders’ equity attributable to AXIL Brands, Inc.			13,737,511				13,144,217
Noncontrolling interests			149,670				—
Total Equity			13,887,181				13,144,217
TOTAL LIABILITIES AND EQUITY		$	18,583,710			$	17,957,235

AXIL BRANDS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED AUGUST 31, 2026 AND 2025

(UNAUDITED)

		For the Three Months Ended August 31,
		2026				2025
Revenues, net		$	6,090,383			$	6,856,218
Cost of revenues			1,058,654				2,221,284
Gross profit			5,031,729				4,634,934
OPERATING EXPENSES:
Sales and marketing			2,837,371				2,759,757
Compensation and related taxes			373,599				396,706
Research and development			459,631				—
General and administrative			924,101				1,066,733
Total Operating Expenses			4,594,702				4,223,196
INCOME FROM OPERATIONS			437,027				411,738
OTHER INCOME (EXPENSE):
Other income			1,883				1,318
Interest income			81,251				37,579
Interest expense and other finance charges			—				(1,283	)
Other income, net			83,134				37,614
INCOME BEFORE PROVISION FOR INCOME TAXES			520,161				449,352
Provision for income taxes			99,590				115,058
NET INCOME		$	420,571			$	334,294
Less: Net loss of subsidiary attributable to noncontrolling interests			(1,021	)			—
Net income attributable to the stockholders of the Company		$	421,592			$	334,294
NET INCOME PER COMMON SHARE:
Basic		$	0.06			$	0.05
Diluted		$	0.05			$	0.04
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic			6,805,199				6,638,785
Diluted			8,252,165				8,243,025

  

AXIL BRANDS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED AUGUST 31, 2026 AND 2025

(UNAUDITED)

		For the Three Months Ended
		August 31,
		2026				2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net income		$	420,571			$	334,294
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization			65,538				62,087
Provision (Recovery) for credit losses			(32,014	)			(158	)
Stock-based compensation and stock option expense			322,393				199,212
Deferred income taxes			(189,659	)			(75,943	)
Change in operating assets and liabilities:
Accounts receivable			3,454,585				(1,774,648	)
Inventory			(19,312	)			(1,355,804	)
Prepaid expenses and other current assets			(244,716	)			12,290
Accounts payable			451,176				1,525,180
Other current liabilities			(353,891	)			383,246
Contract liabilities			(111,912	)			(48,950	)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES			3,762,759				(739,194	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of intangibles			(109,880	)			(86,130	)
Purchases of property and equipment			(55,333	)			(8,367	)
NET CASH USED IN INVESTING ACTIVITIES			(165,213	)			(94,497	)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of note payable			—				(1,030	)
Advances from a related party			56,453				1,207,693
Repayments to a related party			(187,452	)			(1,056,202	)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES			(130,999	)			150,461
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS			3,466,547				(683,230	)
CASH AND CASH EQUIVALENTS – Beginning of period			4,462,040				4,769,854
CASH AND CASH EQUIVALENTS – End of period		$	7,928,587			$	4,086,624
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for:
Interest		$	—			$	1,134
Income taxes		$	18,656			$	—

AXIL Brands will host a conference call to discuss results and provide a corporate update for investors, including a Q&A session, starting at 5:00 PM ET today (October 6, 2026). To access the live event, dial 1-877-425-9470 (Domestic) or 1-201-389-0878 (International), or via webcast at https://viavid.webcasts.com/starthere.jsp?ei=1777813&tp_key=7330938b30. The call will be available via telephone replay for seven days following the call by dialing 1-844-512-2921 (Domestic) or 1-412-317-6671 (International) with access code 13762995. A webcast (audio stream) replay will also be available on demand at www.goaxil.com in the investor relations section.

Questions may be submitted in advance to investors@goaxil.com

About AXIL Brands

AXIL Brands (NYSE American: AXIL) is an emerging global consumer products company. The Company is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL^® brand, premium hair and skincare products under its in-house Reviv3^® brand – selling products in the United States, Canada, the European Union, and throughout Asia and provides marketing services to third-party brands.

To learn more, please visit the Company’s AXIL^® website at www.axilbrands.com and its Reviv3^® website at www.reviv3.com.  

Forward-Looking Statements

This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as “anticipate,” “believe,” “expect,” “continue,” “will,” “may,” “prepare,” “should,” and “focus,” among others, generally identify forward-looking statements. These forward-looking statements are based on currently available information, and management’s beliefs, projections, and current expectations, and are subject to a number of significant risks and uncertainties, many of which are difficult to predict and beyond management’s control and may cause the Company’s results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) the Company’s ability to grow its net revenues and operations, including developing new and improved products, diversifying and expanding its distribution and retail channels, expanding the marketing services business, and growing internationally; (ii) the Company’s ability to perform in accordance with any guidance provided by management, which may differ from the Company’s actual operating results; (iii) the Company’s ability to generate sufficient revenue to support the Company’s operations and to raise additional funds or obtain other forms of financing as needed on acceptable terms, or at all; (iv) potential difficulties or delays the Company may experience in implementing its cost savings and efficiency initiatives; (v) the Company’s ability to compete effectively with other companies in its industries; (vi) the concentration of the Company’s customers, potentially increasing the negative impact to the Company by changing purchasing or selling patterns; (vii) changes in laws or regulations in the United States and/or in other major markets, such as China, in which the Company operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase the Company’s product costs and other costs of doing business, and reduce the Company’s earnings; (viii) continued uncertainty with respect to U.S. trade policies and tariffs; (ix) the Company’s ability to engage in acquisitions, investments,  partnerships, strategic alliances or dispositions when desired; (x) the Company’s ability to successfully accelerate its supply chain transition strategy and achieve the intended benefits; (xi) the impact of unstable market and general economic conditions on the Company’s business, financial condition and stock price, including inflationary cost pressures, the possibility of an economic recession and other macroeconomic factors, geopolitical events, and uncertainty, increased tariffs and other trade restrictions and barriers, unemployment rates, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, the Ukraine-Russia conflict and conflicts in the Middle East, and other downturns in the business cycle or the economy; and (xii) the success of new product and branding initiatives, including the XCOR II launch, including the conversion of orders into revenue, which may be affected by order cancellations and returns, and the planned relaunch of the Reviv3 brand. There can be no assurance as to any of these matters, and potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. Other important factors that may cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company’s filings with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

Investor Relations:
investors@goaxil.com 

Final antidumping and countervailing duty orders on Chinese van-type trailers and subassemblies follow affirmative Commerce and ITC determinations; Section 232 steel and aluminum tariffs continue to apply to imported trailers

LAFAYETTE, Ind., Oct. 06, 2026 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), a member of the American Trailer Manufacturers Coalition (ATMC), today provided an update on U.S. trade actions affecting the North American trailer market. The update covers the antidumping (AD) and countervailing duty (CVD) investigations of van-type trailers and subassemblies from China, Canada, and Mexico, and the Section 232 steel and aluminum tariffs that apply to imported trailers.

China: Final affirmative determinations

On September 25, 2026, the U.S. International Trade Commission (ITC) found that imports of van-type trailers and subassemblies from China materially injure the U.S. industry. The vote followed the U.S. Department of Commerce’s August 26, 2026 final findings of dumping and subsidies, and Commerce will now issue duty orders. Trailers assembled in Canada from Chinese subassemblies are treated as Chinese products and are subject to the China duties.

Canada and Mexico: Preliminary affirmative, final decisions pending

Commerce has issued preliminary affirmative antidumping determinations for Canada and Mexico and a preliminary affirmative countervailing duty determination for Mexico. Importers are now posting cash deposits at those rates. Final Commerce determinations are expected on or around December 17, 2026, followed by final ITC votes in early 2027. Because the petitions against all three countries were filed together, the ITC evaluates their imports on a combined basis, and Wabash expects the Canada and Mexico determinations to be affirmative as well.

Section 232: Steel and aluminum tariffs on imported trailers

Imported trailers are also subject to Section 232 tariffs on steel and aluminum. Trailers are covered as derivative products of steel and aluminum. Since April 6, 2026, the 25 percent Section 232 tariff has applied to the full declared value of an imported trailer rather than only to the value of its steel and aluminum content. Section 232 tariffs are separate from antidumping and countervailing duties, and they stack on top of those duties.

How the duties apply

Antidumping duties, countervailing duties, and Section 232 tariffs are each calculated as a percentage of the declared customs value of the imported trailer, which is approximately $35,000 for a typical van trailer. The table below illustrates the combined effect at current rates.

On a $35,000 declared value	China	Canada	Mexico
Antidumping cash deposit	129.73% = $45,406 (final)	4.29% = $1,502 (preliminary)	7.10% = $2,485 (preliminary)
Countervailing duty	134.75% = $47,163 (final)	Not applicable	1.91% = $669 (preliminary)
Section 232 (steel and aluminum)	25% = $8,750	25% = $8,750	25% = $8,750
Total duties per trailer	About $101,300	About $10,250	About $11,900

Canada and Mexico figures use Commerce’s preliminary “all others” rates; company-specific rates vary. China figures use the final China-wide antidumping cash deposit rate and the final subsidy rate. Rates for Canada and Mexico may change at the final determinations.

Rates for leading import competitors

Commerce has set rates that apply to two of the leading foreign producers in the cases. CIMC (China International Marine Containers) builds dry van and refrigerated trailer kits and subassemblies in China, and its Vanguard affiliates assemble and sell them in the United States. Vanguard’s trailers assembled in Canada from Chinese subassemblies are treated as Chinese products. Hyundai Translead exports van trailers to the United States from its plant in Mexico. Wabash estimates that Hyundai and Vanguard together represent approximately 40 percent of U.S. dry van industry capacity, so the duties and tariffs on these two producers affect a substantial share of the market. Fully stacked, the duties on a trailer declared at $35,000 are as follows:

On a $35,000 declared value	CIMC / Vanguard (China; includes Canadian-assembled trailers with Chinese subassemblies)		Hyundai (Hyundai de Mexico S.A. de C.V.)
Antidumping	129.73% cash deposit (130.86% margin, China-wide rate) = $45,406 (final)		8.35% cash deposit (10.19% margin) = $2,923 (preliminary)
Countervailing duty	134.75% (CIMC Baowell Industries and Qingdao CIMC Reefer Trailer) = $47,163 (final)		1.90% = $665 (preliminary)
Section 232 (steel and aluminum)	25% = $8,750		25% = $8,750
Fully stacked rate	289.48%		35.25%
Total duties per trailer	About $101,300		About $12,340
Landed cost before freight	About $136,300		About $47,340

Hyundai’s antidumping and countervailing duty rates are preliminary and may change when Commerce issues its final Mexico determinations, expected on or around December 17, 2026. Antidumping cash deposit rates are adjusted for subsidy offsets. Landed cost equals the declared value plus duties and excludes freight, brokerage, and other charges.

Summary of current status

Action	China	Canada	Mexico
Commerce – antidumping	Final affirmative (Aug. 26, 2026): 130.86%	Preliminary affirmative (July 30, 2026): 4.29%–44.86%; final expected ~Dec. 17, 2026	Preliminary affirmative (July 30, 2026): 3.21%–79.92%; final expected ~Dec. 17, 2026
Commerce – countervailing duty	Final affirmative (Aug. 26, 2026): 134.75%	Terminated (petition withdrawn, June 2026)	Preliminary affirmative (June 2, 2026): 1.90%–62.67%; final aligned with AD
ITC – injury	Final affirmative (Sept. 25, 2026)	Final vote expected early 2027	Final vote expected early 2027
Section 232 (steel and aluminum)	25% of full declared value of imported trailers (since Apr. 6, 2026); stacks with AD/CVD	Same	Same

Management commentary

“The final decision on China confirms what American trailer manufacturers and their employees have seen for years: unfairly traded imports took market share and pushed prices down,” said Brent Yeagy, President and Chief Executive Officer of Wabash. “Hyundai and Vanguard together represent approximately 40 percent of U.S. dry van industry capacity, so these duties and tariffs reach a substantial share of the market. We are encouraged by the preliminary findings on Canada and Mexico and will keep working with the Department of Commerce and the ITC through the final phase. Our focus has not changed. We are investing in American manufacturing, serving our customers, and competing on a level playing field.”

Wabash sources about 95 percent of its materials from U.S. suppliers. It recently added 10,000 units of dry-van capacity at its Lafayette South facility.

About Wabash

Wabash (NYSE: WNC) combines physical and digital technologies to deliver innovative, end-to-end solutions that optimize supply chains across transportation, logistics and infrastructure markets. Headquartered in Lafayette, Indiana, Wabash designs, manufactures, and services an extensive range of products supporting first-to-final mile operations, including dry and refrigerated trailers and truck bodies, platform trailers, tank trailers, structural composites and more. In addition, through the Wabash Marketplace and Wabash Parts, customers gain access to a nationwide parts and service network, Trailers as a Service (TaaS)℠, and advanced tools designed to streamline operations and drive growth. By enabling businesses to thrive today and prepare for tomorrow, Wabash is Changing How the World Reaches You®. Learn more at onewabash.com.

Forward-Looking Statements

This press release contains certain forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements convey the Company’s current expectations or forecasts of future events. All statements contained in this press release other than statements of historical fact are forward-looking statements.

These forward-looking statements include, among other things, all statements regarding the timing and outcome of pending antidumping and countervailing duty proceedings, the issuance and effect of duty orders, the application of Section 232 steel and aluminum tariffs, the Company’s outlook for trailer and truck body shipments, backlog, expectations regarding demand levels for trailers, truck bodies, non-trailer equipment and our other diversified product offerings, pricing, profitability and earnings, cash flow and liquidity, opportunity to capture higher margin sales, new product innovations, our growth and diversification strategies, our expectations for improved financial performance during the course of the year and our expectations with regards to capital allocation.

These and the Company’s other forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements.

Without limitation, these risks and uncertainties include the risks related to highly cyclical nature of our business, uncertain economic conditions including the possibility that customer demand may not meet our expectations, our backlog may not reflect future sales of our products, increased competition, reliance on certain customers and corporate partnerships, risks of customer pick-up delays, shortages and costs of raw materials including the impact of tariffs or other international trade developments, final determinations in trade proceedings that differ from preliminary determinations, changes in trade policy, risks in implementing and sustaining improvements in the Company’s manufacturing operations and cost containment, dependence on industry trends and timing, supplier constraints, labor costs and availability, customer acceptance of and reactions to pricing changes, costs of indebtedness, and our ability to execute on our long-term strategic plan. Readers should review and consider the various disclosures made by the Company in this press release and in the Company’s reports to its stockholders and periodic reports on Forms 10-K and 10-Q.

Media Contact

wabashprteam@padillaco.com

Investor Relations

John Cummings, Sr. Director, FP&A and Investor Relations | (765) 262-2898 | john.cummings@onewabash.com